Advanced Solutions announced partnerships with the leading medical and research technology solution providers in Qatar and the UAE.

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare.

Review the different considerations required for developing facilities centered around 3D bioprinting technologies.

BioAssemblyBot® 200, or BAB200 as we call her, is an all-in-one platform that takes you from the idea stage quickly to execution.

3D structures made of collagen using mold design and fabrication

The Integrated biofabrication platform that is TSIM® and the BioAssemblyBot® 400 enables the intuitive fabrication of microfluidic systems.

Dr. Vahid Serpooshan, at Emory/Georgia Tech University, recently published work on the biofabrication of bacteriostatic bone constructs.

In vitro models of human liver tissue and function are proving invaluable in liver disease modelling, hepatotoxicity screening for drugs,...

Dr. Vahid Serpooshan, at Emory/Georgia Tech University, has published a review on the state of field of bioprinting for neural tissues....

Organoids are invaluable tools for disease modeling and high throughput screening. The majority of organoids contain one or two cell...

Advanced Solutions’ Chief Scientist, Dr. Jay Hoying, will be presenting at the Olympus® Discovery Summit at the end of this month.

Advanced Solutions’ groundbreaking research into vascularization is featured in the April edition of SME’s SMART Manufacturing....

Build complex tissue models with one click using Advanced Solutions BioApps.

The BioAssemblyBot® Platform can be used to fabricate mesh or weave-like patterns to generate constructs with varying porosity.

A patch is being printed onto the complex surface of a printed three-dimension model of a heart, generated from patient data.

Join Dr. Jay Hoying, Advanced Solutions Chief Scientist, at the virtual 10th Annual Laboratory Animal Sciences conference.

Hello, versatility. Advanced Solutions announces their newest patented, cGMP and UL certified bioprinter, the BioAssemblyBot® 200.

Polydimethylsiloxane (PDMS) is a well-known and widely used viscoelastic biomaterial with applications across the tissue engineering.

In this article we examine printing a gelatin/alginate blend with incorporated cells using the BioBot Basic.

An automated ELISA-based protocol for detecting COVID-19 related antibodies with an automated workflow using BioAssemblyBot and BioApps.